Sucampo Appoints Cary J. Claiborne as Chief Financial Officer

Sucampo Pharmaceuticals, Inc.

today announced the appointment of Cary J. Claiborne as SPI's Chief Financial Officer, effective immediately, reporting to Ryuji Ueno, M.D., Ph.D., Ph.D., Chairman and Chief Executive Officer, and James J. Egan, Chief Operating Officer, of SPI. Mr. Claiborne has been Sucampo's Interim CFO since March 2011.